
Specialist in Internal Medicine, Hospital Universitario Miguel Servet (Zaragoza)
Dr. Luis Sáez Comet graduated in Medicine from the University of Zaragoza (1993), completed his PhD in Medicine at the same institution (2001), and attended the EULAR nailfold capillaroscopy course in Genoa (2008). Since June 2006, he has worked as an internist in the Unidad de Enfermedades Autoinmunes Sistémicas (UEAS) within the Internal Medicine Department at Hospital Universitario Miguel Servet (Zaragoza). His research and clinical work include capillaroscopy, systemic sclerosis, antiphospholipid syndrome, systemic lupus erythematosus, and other systemic autoimmune diseases.
Dr. Sáez Comet served as Associate Professor at the Faculty of Medicine of the University of Zaragoza (2007-2023) and has been Professor Vinculado Doctor since November 2023, teaching pathophysiology, medical semiology, and immunopathology. He has supervised undergraduate and master's theses, including projects on nailfold capillaroscopy, as well as multiple doctoral theses. He belongs to the GEAS working group on systemic autoimmune diseases within the Spanish Society of Internal Medicine (SEMI), where he served on the executive board coordinating the systemic sclerosis and antiphospholipid syndrome lines until 2025. He is also a founding member of the Spanish Capillaroscopy Group (GREC), contributed to the development of the Capilaroscopia Periungueal app for Android and iOS, and has coordinated and taught multiple nailfold capillaroscopy seminars.
Contributed cases and studies (1)
Anti-NXP2 Dermatomyositis with Capillaroscopic Improvement
A 21-year-old woman with anti-NXP2-positive dermatomyositis followed with two capillaroscopies before and after immunosuppressive treatment.
Images in the atlas (2)
Anti-NXP2 dermatomyositis: initial enlarged loopsProminent enlarged loops and a complex branching form in the initial anti-NXP2 dermatomyositis study. Compare this with the linked follow-up image and complete serial studies.
View the complete study
Anti-NXP2 dermatomyositis: follow-up fieldFollow-up field from the adult anti-NXP2 dermatomyositis case. The source report documents improved study-wide density and disappearance of giants and hemorrhages; these are longitudinal study findings.
View the complete study